Medical and Device Therapy for Stroke Prevention in Patients With Atrial Fibrillation-Reference-Cited by-同舟云学术

Medical and Device Therapy for Stroke Prevention in Patients With Atrial Fibrillation

Published:2021-09-01 Issue:4 Volume:48 Page:
ISSN:1526-6702
Container-title:Texas Heart Institute Journal
language:en
Short-container-title:

Author:

Huang Sophia¹,Safavi-Naeini Payam²,Rasekh Abdi¹

Affiliation:

1. Section of Cardiology, Baylor College of Medicine, Houston, Texas

2. Department of Cardiology, Texas Heart Institute, Houston, Texas

Publisher

Texas Heart Institute Journal

Subject

Cardiology and Cardiovascular Medicine

Link

http://meridian.allenpress.com/thij/article-pdf/doi/10.14503/THIJ-21-7549/2935333/i1526-6702-48-4-e217549.pdf

Reference27 articles.

1. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) [published errata appear in Eur Heart J 2021;42(5):507 and Eur Heart J 2021;42(5):546–7];Hindricks;Eur Heart J,2021

2. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) [published erratum appears in J Am Coll Cardiol 2007;50(6):562];European Heart Rhythm Association;J Am Coll Cardiol,2006

3. Atrial fibrillation and mechanisms of stroke: time for a new model;Kamel;Stroke,2016

4. Where we stand on left atrial appendage closure for stroke prevention in atrial fibrillation;Safavi-Naeini;Tex Heart Inst J,2016

5. NOACs versus warfarin for stroke prevention in patients with AF: a systematic review and meta-analysis;Hicks;Open Heart,2016